Neurocrine Biosciences Inc. (NASDAQ: NBIX) started the day on January 06, 2021, with a price increase of 0.32% at $97.45. During the day, the stock rose to $97.79 and sunk to $95.29 before settling in for the price of $97.14 at the close. Taking a more long-term approach, NBIX posted a 52-week range of $72.14-$136.26.
Meanwhile, its Annual Earning per share during the time was 19.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 74.70%. This publicly-traded company’s shares outstanding now amounts to $93.30 million, simultaneously with a float of $90.70 million. The organization now has a market capitalization sitting at $9.07 billion. At the time of writing, stock’s 50-day Moving Average stood at $95.55, while the 200-day Moving Average is $106.86.
It is quite necessary to find out the efficiency of the corporate organization, which has 700 number of employees on its payroll. It has generated 1,125,839 per worker during the last fiscal year. Meanwhile, its income per employee was 52,874. The stock had 8.62 Receivables turnover and 0.69 Total Asset turnover. For the Profitability, stocks gross margin was +98.11, operating margin was +28.75 and Pretax Margin of +5.91.
Neurocrine Biosciences Inc. (NBIX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Neurocrine Biosciences Inc.’s current insider ownership accounts for 1.00%, in contrast to 98.00% institutional ownership. According to the most recent insider trade that took place on Dec 01, this organization’s Chief Financial Officer sold 1,645 shares at the rate of 94.66, making the entire transaction reach 155,721 in total value, affecting insider ownership by 11,494. Preceding that transaction, on Nov 12, Company’s Chief Commercial Officer sold 2,257 for 90.71, making the whole transaction’s value amount to 204,723. This particular insider is now the holder of 17,405 in total.
Neurocrine Biosciences Inc. (NBIX) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2020, the organization reported -$0.62 earnings per share (EPS) for the three months, lower than the consensus estimate (set at $0.22) by -$0.84. This company achieved a net margin of +4.70 while generating a return on equity of 6.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.5 per share during the current fiscal year.
Neurocrine Biosciences Inc.’s EPS increase for this current 12-month fiscal period is 74.70% and is forecasted to reach 3.35 in the upcoming year.
Neurocrine Biosciences Inc. (NASDAQ: NBIX) Trading Performance Indicators
Let’s observe the current performance indicators for Neurocrine Biosciences Inc. (NBIX). It’s Quick Ratio in the last reported quarter now stands at 1.90. The Stock has managed to achieve an average true range (ATR) of 3.00. Alongside those numbers, its PE Ratio stands at $105.01, and its Beta score is 1.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.70. Similarly, its price to free cash flow for trailing twelve months is now 38.92.
In the same vein, NBIX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.93, a figure that is expected to reach 0.59 in the next quarter, and analysts are predicting that it will be 3.35 at the market close of one year from today.
Technical Analysis of Neurocrine Biosciences Inc. (NBIX)
If we take a close look at the recent performances of Neurocrine Biosciences Inc. (NASDAQ: NBIX), its last 5-days Average volume was 0.61 million that shows plunge from its year to date volume of 0.67 million. During the previous 9 days, stock’s Stochastic %D was recorded 53.11% While, its Average True Range was 3.04.
Raw Stochastic average of Neurocrine Biosciences Inc. (NBIX) in the period of the previous 100 days is set at 34.90%, which indicates a major fall in contrast to 49.27% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 23.96% that was lower than 50.55% volatility it exhibited in the past 100-days period.